Cite
Søfteland JM, Gisslén M, Liljeqvist JÅ, et al. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. Am J Transplant. 2021;doi: 10.1111/ajt.16909.
Søfteland, J. M., Gisslén, M., Liljeqvist, J. �. �., Friman, V., de Coursey, E., Karason, K., Ekelund, J., Felldin, M., Magnusson, J., Baid-Agrawal, S., Wallquist, C., Schult, A., Jacobsson, H., Bergdahl, A., Bemark, M., Andersson, L. M., Holm Gunnarsson, I., Stenström, J., & Leach, S. (2021). Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, . https://doi.org/10.1111/ajt.16909
Søfteland, John M, et al. "Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls." American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. (2021). doi: https://doi.org/10.1111/ajt.16909
Søfteland JM, Gisslén M, Liljeqvist JÅ, Friman V, de Coursey E, Karason K, Ekelund J, Felldin M, Magnusson J, Baid-Agrawal S, Wallquist C, Schult A, Jacobsson H, Bergdahl A, Bemark M, Andersson LM, Holm Gunnarsson I, Stenström J, Leach S. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls. Am J Transplant. 2021 Dec 03; doi: 10.1111/ajt.16909. Epub 2021 Dec 03. PMID: 34860447.
Copy
Download .nbib